Publications:

Efficacy and Safety of EGFR Tyrosine Kinase Inhibitors Combined with Cranial Radiotherapy for Brain Metastases from Non-Small-Cell Lung Cancer: A Protocol for a Systematic Review and Meta-Analysis.

Biomed Research International

Ge, Yuansha Y; Xu, Bowen B; Wang, Heping H; Gao, Junmao J; Zhang, Xiaoxiao X; Lu, Taicheng T; Gao, Ruike R; Li, Jie J

Publication Date: 2022

Variant appearance in text: EGFR: e455S

PubMed Link: 35872868

Variant Present in the following documents:

• BMRI2022-6531748.pdf

View BVdb publication page

Comparing the efficacy of concurrent EGFR-TKI and whole-brain radiotherapy vs EGFR-TKI alone as a first-line therapy for advanced EGFR-mutated non-small-cell lung cancer with brain metastases: a retrospective cohort study.

Cancer Management And Research

He, Zhi-Yong ZY; Li, Mei-Fang MF; Lin, Jing-Hui JH; Lin, Dong D; Lin, Ren-Jang RJ

Publication Date: 2019

Variant appearance in text: EGFR: e455S

PubMed Link: 30936745

Variant Present in the following documents:

• cmar-11-2129.pdf

View BVdb publication page

Symptom burden in lung cancer: management updates.

Lung Cancer Management

Lehto, Rebecca H RH

Publication Date: 2016-06

Variant appearance in text: EGFR: e455S

PubMed Link: 30643551

Variant Present in the following documents:

• Main text

View BVdb publication page

ALK: a tyrosine kinase target for cancer therapy.

Cold Spring Harbor Molecular Case Studies

Holla, Vijaykumar R VR; Elamin, Yasir Y YY; Bailey, Ann Marie AM; Johnson, Amber M AM; Litzenburger, Beate C BC; Khotskaya, Yekaterina B YB; Sanchez, Nora S NS; Zeng, Jia J; Shufean, Md Abu MA; Shaw, Kenna R KR; Mendelsohn, John J; Mills, Gordon B GB; Meric-Bernstam, Funda F; Simon, George R GR

Publication Date: 2017-01

Variant appearance in text: EGFR: e455S

PubMed Link: 28050598

Variant Present in the following documents:

• HollaMCS001115.pdf

View BVdb publication page